BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maida M, Orlando E, Cammà C, Cabibbo G. Staging systems of hepatocellular carcinoma: A review of literature. World J Gastroenterol 2014; 20(15): 4141-4150 [PMID: 24764652 DOI: 10.3748/wjg.v20.i15.4141]
URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4141.htm
Number Citing Articles
1
Amy Leigh Collinsworth. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 17 doi: 10.1007/978-3-319-68082-8_2
2
Yan Mardian, Yoshihiko Yano, Neneng Ratnasari, Lina Choridah, Widya Wasityastuti, Nurhuda Hendra Setyawan, Yoshitake Hayashi. “Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study”BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1152-4
3
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]2019;  doi: 10.5772/intechopen.86638
4
Jun-Cheng Wang, Jing-Yu Hou, Jian-Cong Chen, Cai-Ling Xiang, Xian-Hai Mao, Bing Yang, Qiang Li, Qing-Bo Liu, Jinbin Chen, Zhi-Wei Ye, Wei Peng, Xu-Qi Sun, Min-Shan Chen, Qun-Fang Zhou, Yao-Jun Zhang. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resectionEuropean Journal of Cancer 2021; 155: 85 doi: 10.1016/j.ejca.2021.07.009
5
Elise Verger, Pierre Drion, Geneviève Meffre, Claire Bernard, Luc Duwez, Nicolas Lepareur, Olivier Couturier, François Hindré, Roland Hustinx, Franck Lacoeuille, Hélder A. Santos. 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat StudiesPLOS ONE 2016; 11(10): e0164626 doi: 10.1371/journal.pone.0164626
6
In-Gyu Kim, Xu-Guang Hu, Hee-Jung Wang, Bong-Wan Kim, Sung Yeon Hong, Xue-Yin Shen. The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular CarcinomaYonsei Medical Journal 2019; 60(2): 140 doi: 10.3349/ymj.2019.60.2.140
7
Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Luca Marzi, Carlo Saitta, Jean-Charles Nault, Rodolfo Sacco. The calm before the storm: a report from the International Liver Cancer Association Congress 2015 – part 1Future Oncology 2016; 12(3): 281 doi: 10.2217/fon.15.323
8
Wylly Ramsés García-Niño, Cecilia Zazueta. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protectionPharmacological Research 2015; 97: 84 doi: 10.1016/j.phrs.2015.04.008
9
Akshay D. Baheti, Gregor M. Dunham, Christopher R. Ingraham, Mariam Moshiri, Chandana Lall, James O. Park, David Li, Douglas S. Katz, David C. Madoff, Puneet Bhargava. Clinical implications for imaging of vascular invasion in hepatocellular carcinomaAbdominal Radiology 2016; 41(9): 1800 doi: 10.1007/s00261-016-0763-2
10
Gerd Otto, Michael B Pitton, Maria Hoppe-Lotichius, Arndt Weinmann. Liver transplantation and BCLC classification: Limitations impede optimum treatmentHepatobiliary & Pancreatic Diseases International 2021; 20(1): 6 doi: 10.1016/j.hbpd.2020.12.009
11
Edward Wolfgang Lee, Lourdes Alanis, Sung-Ki Cho, Sammy Saab. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature ReviewKorean Journal of Radiology 2016; 17(4): 472 doi: 10.3348/kjr.2016.17.4.472
12
Philip M. Hemken, Lori J. Sokoll, Xiaoqing Yang, Jianliang Dai, Debra Elliott, Susan H. Gawel, Michael Lucht, Ziding Feng, Jorge A. Marrero, Sudhir Srivastava, Daniel W. Chan, Gerard J. Davis. Validation of a novel model for the early detection of hepatocellular carcinomaClinical Proteomics 2019; 16(1) doi: 10.1186/s12014-018-9222-0
13
Su Jong Yu. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Clinical and Molecular Hepatology 2016; 22(1): 7 doi: 10.3350/cmh.2016.22.1.7
14
Li‐Ju Chen, Yun‐Jau Chang, Yao‐Jen Chang. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular CarcinomaThe Oncologist 2021; 26(3) doi: 10.1002/onco.13535
15
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_188-1
16
Annacarmen Petrizzo, Luigi Buonaguro. Application of the Immunoscore as prognostic tool for hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2016; 4(1) doi: 10.1186/s40425-016-0182-5
17
Xiao‐Hui Wang, Bing Liao, Wen‐Jie Hu, Cai‐Xue Tu, Cai‐Ling Xiang, Sheng‐Hua Hao, Xian‐Hai Mao, Xiao‐Ming Qiu, Xiao‐Jun Yang, Xiao Yue, Ming Kuang, Bao‐Gang Peng, Shao‐Qiang Li. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus‐Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor ThrombusThe Oncologist 2020; 25(10) doi: 10.1634/theoncologist.2019-0766
18
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An updateWorld Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
19
Yin Lai, Jin‐Chiao Lee, Hao‐Chien Hung, Chih‐Hsien Cheng, Tsung‐Han Wu, Chen‐Fang Lee, Ting‐Jung Wu, Hong‐Shiue Chou, Kun‐Ming Chan, Wei‐Chen Lee. Models to predict disease‐free survival for hepatocellular carcinoma patients with surgical resectionsJournal of Surgical Oncology 2020; 122(7): 1444 doi: 10.1002/jso.26169
20
Giuseppe Cabibbo, Michela Antonucci, Rodolfo Sacco, Elio Sciarrino. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?Expert Review of Anticancer Therapy 2015; 15(2): 147 doi: 10.1586/14737140.2015.1001374
21
Chen Jin, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Bo Li, Wen-Tao Wang, Jia-Yin Yang, Ming-Qing Xu. Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survivalMedicine 2017; 96(33): e7821 doi: 10.1097/MD.0000000000007821
22
Eun-Suk Cho, Jin-Young Choi. MRI Features of Hepatocellular Carcinoma Related to Biologic BehaviorKorean Journal of Radiology 2015; 16(3): 449 doi: 10.3348/kjr.2015.16.3.449
23
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsWorld Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
24
Abdelfattah M. Attallah, Mohamed M. Omran, Ahmed A. Attallah, Mohamed A. Abdelrazek, Khaled Farid, Ibrahim El-Dosoky. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systemsInternational Journal of Clinical Oncology 2017; 22(2): 332 doi: 10.1007/s10147-016-1066-x
25
Wafaa Mohammed ElZefzafy, Magda Hussien, Zakia Abu Zahab Mohmmed, Nashwa Mohammed Abd Elbaky. The diagnostic value of golgi protien-73 and DICKKOPF-1 in hepatocellular carcinomaJournal of Immunoassay and Immunochemistry 2021; 42(2): 174 doi: 10.1080/15321819.2020.1844750
26
Ting Lin, Jingxian Gu, Kai Qu, Xing Zhang, Xiaohua Ma, Runchen Miao, Xiaohong Xiang, Yunong Fu, Wenquan Niu, Junjun She, Chang Liu. A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosisAging 2018; 10(9): 2480 doi: 10.18632/aging.101563
27
James Weiquan Li, Boon-Bee George Goh, Pik-Eu Chang, Chee-Kiat Tan. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspectiveWorld Journal of Gastroenterology 2017; 23(22): 4054-4063 doi: 10.3748/wjg.v23.i22.4054
28
Brian I. Carr. Liver Cancer in the Middle East2021; : 111 doi: 10.1007/978-3-030-78737-0_7
29
Omar M Abdel-Rahman, Zeinab Elsayed, Omar M Abdel-Rahman. Cochrane Database of Systematic Reviews2014;  doi: 10.1002/14651858.CD011314
30
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCCHepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
31
Teresa Marzia Rogger, Andrea Michielan, Sandro Sferrazza, Cecilia Pravadelli, Luisa Moser, Flora Agugiaro, Giovanni Vettori, Sonia Seligmann, Elettra Merola, Marcello Maida, Francesco Antonio Ciarleglio, Alberto Brolese, Giovanni de Pretis. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literatureWorld Journal of Gastroenterology 2020; 26(35): 5375-5386 doi: 10.3748/wjg.v26.i35.5375
32
Akiyoshi Kinoshita, Hiroshi Onoda, Nao Fushiya, Kazuhiko Koike, Hirokazu Nishino, Hisao Tajiri. Staging systems for hepatocellular carcinoma: Current status and future perspectivesWorld Journal of Hepatology 2015; 7(3): 406-424 doi: 10.4254/wjh.v7.i3.406
33
Han Qi, Weijun Fan. Value of ablation therapy in the treatment of lung metastasesThoracic Cancer 2018; 9(2): 199 doi: 10.1111/1759-7714.12567
34
Yukio Tokumitsu, Hiroaki Nagano. Hepatocellular Carcinoma2016; : 425 doi: 10.1007/978-3-319-34214-6_28
35
Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, Gabriele Missale, Roberto Virdone, Eugenio Caturelli, Fabio Piscaglia, Filomena Morisco, Antonio Colecchia, Fabio Farinati, Edoardo Giannini, Franco Trevisani, Antonio Craxì, Massimo Colombo, Calogero Cammà. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinomaLiver International 2017; 37(8): 1157 doi: 10.1111/liv.13357
36
Anthony W. H. Chan, Stephen L. Chan, Frankie K. F. Mo, Grace L. H. Wong, Vincent W. S. Wong, Yue-Sun Cheung, Henry L. Y. Chan, Winnie Yeo, Paul B. S. Lai, Ka-Fai To. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular CarcinomaDisease Markers 2015; 2015: 1 doi: 10.1155/2015/564057
37
Peng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, Ming-Qing Xu. Liver resection for intermediate hepatocellular carcinomaWorld Journal of Hepatology 2016; 8(14): 607-615 doi: 10.4254/wjh.v8.i14.607
38
Kwang Min Kim, Dong Hyun Sinn, Sin-Ho Jung, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?Liver International 2016; 36(10): 1490 doi: 10.1111/liv.13107
39
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3501 doi: 10.1007/978-3-319-26956-6_188
40
Mauro Borzio, Elena Dionigi, Angelo Rossini, Massimo Marignani, Rodolfo Sacco, Ilario De Sio, Emanuela Bertolini, Giampiero Francica, Anna Giacomin, Giancarlo Parisi, Susanna Vicari, Anna Toldi, Andrea Salmi, Sergio Boccia, Mario Mitra, Fabio Fornari. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort studyHepatology 2018; 67(6): 2215 doi: 10.1002/hep.29662
41
Guoqing Zhang, Renfeng Li, Xiaoyang Zhao, Songfeng Meng, Jianwen Ye, Longshuan Zhao. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based studyJournal of Surgical Research 2018; 222: 55 doi: 10.1016/j.jss.2017.09.044
42
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systemsPLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
43
Thayse Gardini Alvarenga, Pamela Carvalho Muniz, Hakaru Tadokoro, Ramon Andrade De Mello, Nora Manoukian Forones. International Manual of Oncology Practice2019; : 405 doi: 10.1007/978-3-030-16245-0_20
44
Xiao‐Hui Wang, Qing‐Bo Liu, Cai‐Ling Xiang, Xian‐Hai Mao, Bing Yang, Qiang Li, Qun‐Fang Zhou, Shao‐Qiang Li, Zhong‐Guo Zhou, Min‐Shan Chen. Multi‐institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinomaInternational Journal of Cancer 2021; 149(1): 127 doi: 10.1002/ijc.33516
45
Zhi-Ming Zhang, Yu-Mei Zhang, Sheng Gao, Wei-Ping Yuan, Yin-Nong Zhao, Bang-De Xiang, Fei-Xiang Wu, Guo-Bin Wu, Jian-Yong Liu. Treatment Efficacy and Prognostic Factors for Huge HCC Based on Barcelona Clinic Liver Cancer StagingAsian Pacific Journal of Cancer Prevention 2014; 15(20): 8823 doi: 10.7314/APJCP.2014.15.20.8823
46
Konstantinos Damiris, Hamza Abbad, Nikolaos Pyrsopoulos. Cellular based treatment modalities for unresectable hepatocellular carcinomaWorld Journal of Clinical Oncology 2021; 12(5): 290-308 doi: 10.5306/wjco.v12.i5.290
47
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjectsWorld Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
48
CHENG-ZUO XIAO, WEI WEI, ZHI-XING GUO, SHU-HONG LI, YONG-FA ZHANG, JIA-HONG WANG, MING SHI, RONG-PING GUO. A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resectionOncology Letters 2015; 10(5): 2787 doi: 10.3892/ol.2015.3677
49
Berend R. Beumer, Stefan Buettner, Boris Galjart, Jeroen L.A. van Vugt, Robert A. de Man, Jan N.M. IJzermans, Bas Groot Koerkamp. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patientsEuropean Journal of Surgical Oncology 2021;  doi: 10.1016/j.ejso.2021.09.012
50
Patrick Vande Lune, Ahmed K. Abdel Aal, Sergio Klimkowski, Jessica G. Zarzour, Andrew J. Gunn. Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial ChemoembolizationJournal of Clinical and Translational Hepatology 2017; 6(2): 1 doi: 10.14218/JCTH.2017.00045
51
Lihui Su, Tao Zhou, Zongli Zhang, Xiuguo Zhang, Xuting Zhi, Caixia Li, Qingliang Wang, Chongqi Jia, Wenna Shi, Yanqiu Yue, Yanjing Gao, Baoquan Cheng. Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective studyBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2420-0
52
Alessandro Vitale, Fabio Farinati, Michele Finotti, Chiara Di Renzo, Giuseppina Brancaccio, Fabio Piscaglia, Giuseppe Cabibbo, Eugenio Caturelli, Gabriele Missale, Fabio Marra, Rodolfo Sacco, Edoardo Giannini, Franco Trevisani, Umberto Cillo. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC ClassificationsCancers 2021; 13(7): 1673 doi: 10.3390/cancers13071673
53
Omar Abdel-Rahman, Zeinab Elsayed. External beam radiotherapy for unresectable hepatocellular carcinomaCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011314.pub2
54
Tarik Demir, Sunyoung S. Lee, Ahmed O. Kaseb. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 257 doi: 10.1016/bs.acr.2020.12.001
55
Wei-Lun Tsai, Wei-Chi Sun, Wen-Chi Chen, Chia-Ling Chiang, Huey-Shyan Lin, Huei-Lung Liang, Jin-Shiung Cheng. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinomaMedicine 2020; 99(32): e21489 doi: 10.1097/MD.0000000000021489
56
Zhi-Ming Zhang, Yu-Mei Zhang, Feng Yao, Ping Yi, Shang Huang, Jian-Yong Liu, Bang-De Xiang, Wei-Ping Yuan, Le-Qun Li. Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular CarcinomaAsian Pacific Journal of Cancer Prevention 2015; 16(8): 3479 doi: 10.7314/APJCP.2015.16.8.3479
57
Jingxian Gu, Xing Zhang, Zhixin Wang, Ruixia Cui, Jia Zhang, Yifan Jia, Runchen Miao, Haining Fan, Haijiu Wang, Yiming Li, Jingyao Zhang, Chang Liu, Kai Qu. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgerySurgical Oncology 2019; 30: 131 doi: 10.1016/j.suronc.2019.07.008
58
Zhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, Xing Li, Dong-Hao Wu, Jing-Yun Wen, Jie Chen, Dan-Yun Ruan, Qu Lin, Min Dong, Li Wei, Tian-Tian Wang, Ze-Xiao Lin, Xiao-Kun Ma, Xiang-Yuan Wu, Ruihua Xu. Validation and ranking of seven staging systems of hepatocellular carcinomaOncology Letters 2017; 14(1): 705 doi: 10.3892/ol.2017.6222
59
Jong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, Sung-Cheol Yun, Ju Hyun Shim, Han Chu Lee, Danbi Lee, Jihyun An, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Kang Mo Kim. Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular CarcinomaDigestive Diseases and Sciences 2017; 62(10): 2923 doi: 10.1007/s10620-017-4708-6
60
Michele Campigotto, Mauro Giuffrè, Anna Colombo, Alessia Visintin, Alessandro Aversano, Martina Budel, Flora Masutti, Cristiana Abazia, Lory Saveria Crocé. Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literatureWorld Journal of Hepatology 2020; 12(12): 1239-1257 doi: 10.4254/wjh.v12.i12.1239
61
Wan-Yuan Chen, Yong-Kang Diao, Hang-Dong Jia, Lei Liang, Tian Yang. Association Between Olfactomedin 4 and Postoperative Prognosis in Patients With Early-Stage Hepatocellular CarcinomaClinical and Translational Gastroenterology 2020; 11(6): e00163 doi: 10.14309/ctg.0000000000000163